Neutralising antibodies to interferon-beta therapy in relapsing multiple sclerosis: a pilot study

Hong Kong Med J. 2019 Aug;25 Suppl 5(4):22-25.

Authors

A Y L Lau¹, E Chan², K K Lau³, V Mok¹, D Y W Siu⁴, R Lee⁴

Affiliations

¹ Department of Medicine and Therapeutics, The Chinese University of Hong Kong.
² Department of Pathology, Queen Mary Hospital.
³ Department of Medicine, Princess Margaret Hospital.
⁴ Department of Imaging and Interventional Radiology, Prince of Wales Hospital.

PMID: 31416982

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antibodies, Neutralizing / immunology*
Cohort Studies
Enzyme-Linked Immunosorbent Assay
Female
Humans
Interferon-beta / immunology
Interferon-beta / therapeutic use*
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting / immunology
Multiple Sclerosis, Relapsing-Remitting / therapy*
Pilot Projects
ROC Curve
Recurrence

Substances

Antibodies, Neutralizing
Interferon-beta